Report Highlights
The global patient monitoring devices market should reach $42.7 billion by 2022 and more than $65.4 billion by 2027, with a compound annual growth rate (CAGR) of 8.9% during the forecast period of 2022-2027.
Report Includes
- 54 data tables and 24 additional tables
- A comprehensive overview of the global market for patient monitoring devices within the healthcare industry
- Estimation of the market size and analyses of market trends, with data from 2020, 2021, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of the market potential for patient monitoring devices by product types, device categories and end users
- Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size and forecast, and assessment of new developments in the industry
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies and a relevant patent analysis
- Company profiles of major players within the industry, including Abbott Laboratories, Bayer Healthcare AG, GE Healthcare, Medtronic and Philips Healthcare
Report Scope
This report covers a range of products, some are disease specific and others are used for all types of patients and in general for health management. The patient monitoring device market referred to in this report is limited to the devices/products included in this report. Each product market covered in this report is unique and has a different set of market dynamics and competitive landscape. The product lifecycle of each product segment also varies.
The study will enable the audience to understand and gain insights on the current market and will forecast the changing market scenario. The data provided can help users understand which market segments among device connectivity, product type and end users are expected to grow at higher rates: factors driving growth, factors limiting the growth, key opportunity areas and so on.
Discussion and analysis cover the following market factors:
• Key market analysis.
• Market dynamics (drivers and restraints)
• Market forecast period of 2022-2027.
• Competitive developments and landscape.
• Geographic regional analysis.
• Patents.
• Profiles of key market players.
The report also covers a detailed competitive outlook, including market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Abbott Laboratories, GE Healthcare, Philips Healthcare, Nihon Kohden, Omron Healthcare, Roche Diagnostics Ltd., Cardiocom, Covidien, CR Bard, Honeywell Med, Infinium Medical and InTechnology etc.
Report Synopsis
Report Metrics | Details | ||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Base year considered | 2021 | ||||||||||||||||||||||||||||||||||||||||||
Forecast period considered | 2022–2027 | ||||||||||||||||||||||||||||||||||||||||||
Base year market size | $39.5 billion | ||||||||||||||||||||||||||||||||||||||||||
Market size forecast | $65.4 billion | ||||||||||||||||||||||||||||||||||||||||||
Growth rate | CAGR of 8.9% from 2022 to 2027 | ||||||||||||||||||||||||||||||||||||||||||
Units considered | $ Millions | ||||||||||||||||||||||||||||||||||||||||||
Segments covered | Region, Product Type, Equipment/Device Category, Device Connectivity, End User | ||||||||||||||||||||||||||||||||||||||||||
Regions covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) | ||||||||||||||||||||||||||||||||||||||||||
Countries covered | U.S., Canada., Germany., U.K., France., Italy., Spain., Rest of Europe., China., Japan., India., South Korea, Rest of Asia-Pacific. | ||||||||||||||||||||||||||||||||||||||||||
Key Market Drivers |
|
||||||||||||||||||||||||||||||||||||||||||
Companies studied |
|
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Bioprocess Optimization and Digital Bio-manufacturing: Global Markets (BIO170B)
- Metal-organic Frameworks: Global Markets (AVM200B)
- Laboratory Animal Models, 3D Cultures, and Organoids: Global Markets (PHM204C)
- Global DNA Sequencing: Research, Applied and Clinical Markets (BIO045J)
- Surgical Equipment: Technologies and Global Markets (HLC154C)
Report Highlights
The global market for patient monitoring device will grow from $20.3 billion in 2018 to $25.9 billion by 2023 at a compound annual growth rate (CAGR) of 5.0% for the period of 2018-2023.
Report Includes
- 45 data tables and 35 additional tables
- A comprehensive overview of the global market for patient monitoring devices within the healthcare industry
- Country specific data and analysis for United States, Canada, France, Germany, U.K., Spain, China, India, Japan, Middle East and Africa
- Market breakdown for patient monitoring devices by product types, device categories and end users
- Elaboration on the influence of government regulations, technological updates, and the economic factors that affect the growth of the market
- Analyses of the global market trends, strategies, and recommendations in providing the quantitative assessment of the market that can help manufacturers and suppliers understand the growth potential of different market segments
- Company profiles of major players in the market, including Abbott Laboratories, Bayer Healthcare AG, Cardiac Science Corp., Edwards Lifesciences Corp., GE Healthcare, Honeywell International Inc., Medtronic, Omron Corp., Philips Healthcare, Roche Diagnostics, and Siemens Healthcare Inc.
Report Highlights
The global patient monitoring device market reached $15.9 billion and $16.9 billion in 2014 and 2015 respectively. The market should reach $23.8 billion in 2020, increasing at a compound annual growth rate (CAGR) of 7.1% from 2015 to 2020.
Report Includes
- An overview of the global market for patient monitoring devices, accessories, and consumables that are used to measure, display, and document physiological information obtained at regular intervals over time from sensors attached to the patient or other input devices.
- Analyses of global market trends, with data from 2014, 2015, and projections of compound annual growth rates (CAGRs) through 2020.
- Examination of the market for patient monitoring devices and related equipment by application (e.g., intensive care, neonatal/pediatric care), product type (central monitoring stations, portable bedside monitors, wireless/telemetry monitors), and target markets (hospitals, long-term care facilities, and individual consumers).
- Discussion of promising new technologies and products still in the development and testing stages that are likely to be commercialized successfully in the next five years.
- Profiles of major players in the industry.
Report Highlights
The global patient monitoring device (PMD) market is expected to grow from nearly $14.7 billion in 2013 to reach nearly $21.0 billion in 2018, a compound annual growth rate (CAGR) of 7.4% for the period of 2013 to 2018.
Report Includes
- An overview of the global market for patient monitoring devices, accessories, and consumables that are used to measure, display, and document physiological information obtained at regular intervals over time from sensors attached to the patient or other input devices.
- Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
- Examination of the market for patient monitoring devices and related equipment by application (e.g., intensive care, neonatal/pediatric care), product type (central monitoring stations, portable bedside monitors, wireless/telemetry monitors), and target markets (hospitals, long-term care facilities, and individual consumers).
- Discussion of promising new technologies and products still in the development and testing stages that are likely to be commercialized successfully in the next five years.
- Comprehensive company profiles of major players in the industry.
Report Highlights
- The U.S. market for patient monitoring devices, accessories, and consumables was worth nearly $6.2 billion in 2007. The market is projected to grow to almost $6.5 billion in 2008 and $8.6 billion by 2013, representing a compound annual growth rate (CAGR) of 5.7%.
- The monitoring devices segment has the largest share of the market, worth $3.6 billion in 2007 and an estimated $3.8 billion in 2008. This is expected to grow at a CAGR of 6.2% to reach $5.1 billion in 2013.
- Disposable sensors and other consumables generated $2.6 billion in 2007. This should increase to $2.7 billion in 2008 and $3.4 billion in 2013, for a CAGR of 5.1%.
Report Highlights
-
The U.S. market for patient monitoring devices and related consumable supplies such as disposable sensors was worth an estimated $4.3 billion in 2005. The market is projected to grow to $4.6 billion in 2006 and $6.3 billion by 2011, an AAGR of 6.7%.
-
The home-care market has the highest projected growth rate of any market segment (i.e., an average of 13.8% between 2006-2011). Other segments with relatively high growth rates include progressive care/cardio-pulmonary rehabilitation (4.8%) and long term/non-acute care (4.0%).
-
Across the market, there has been a noticeable trend away from bedside and tabletop monitors, towards hand-held and wearable monitors. With a projected growth rate of 12.8%, the market for hand-held and wearable monitors is expected to grow from $1 billion in 2005 (46% of the market, excluding consumables) to over $2 billion (59%) in 2011.
Report Highlights
-
The U.S. market will rise to $4.3 billion by 2008, at an average annual growth rate (AAGR) of 8.1%.
-
The home care market has the highest growth rate of any market segment.
-
Averaging 11.7%/year, the handheld monitor market will reach $1.6 billion in 2008.
-
The phone or wireless telemetry monitor market will reach $405 million in 2008.
Related Reports
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Infusion Pumps and Devices: Technologies and Global Markets
The global market for infusion pumps is expected to grow from $10.1 billion in 2024 and is projected to reach $14.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.7% during the forecast period of 2024 to 2029.
Microelectronic Medical Implants: Products, Technologies & Opportunities
The global market for microelectronic medical implants is expected to grow from $49.0 billion in 2024 and is projected to reach $85.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.7% during the forecast period of 2024 to 2029.
Recent Reports
Surgical Equipment: Technologies and Global Markets
The global market for surgical equipment and technologies was valued at $37.6 billion in 2023. This market is expected to grow from $40.0 billion in 2024 to $56.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More